Oral administration of Bacillus oligonitrophilus KU-1 may prevent tumors

Asian Pacific Journal of Cancer Prevention

Volumn 7, Issue 2, 2006, Pages 343-

  Malkov, Sergey V ^a   Markelov, Vladimir V ^b   Barabanschikov, Boris I ^a   Marotta, Francesco ^c   Trushin, Maxim V ^a,d  

^a KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^b Kazan Rehabilitation Medical Health Center Sanatorium Krutushka   (Russian Federation)

^c S Giuseppe Hospital   (Italy)

^d KAZAN INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

BACILLUS; HUMAN; NEOPLASM; NOTE; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; BACILLUS; HUMANS; NEOPLASMS; PROBIOTICS;

EID: 33748471176     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Lotfy M (2006). Biological activity of bee propolis in health and disease. Asian Pac J Cancer Prev, 7, 22-31.
2. Malkov SV, Markelov VV, Polozov GY, et al.(2005). Antitumor features of Bacillus oligonitrophilus KU-1 strain. J Microbiol Immunol Infect, 38, 96-104.
3. Malkov SV, Markelov VV, Barabanschikov BI, et al.(2006a). Genome rejuvenation and its applications. Biomed Scientist, 50, 45-47.
4. Malkov SV, Markelov VV, Polozov GY, et al.(2006b). Seven-year survival in patient with rectal adenocarcinoma due to a novel bacterial-based therapeutic approach. A case report. Rev Electron Biomed/Electron J Biomed, 2, in press.